Automate Your Wheel Strategy on OMDA
With Tiblio's Option Bot, you can configure your own wheel strategy including OMDA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OMDA
- Rev/Share 4.1291
- Book/Share 3.8626
- PB 5.3876
- Debt/Equity 0.0
- CurrentRatio 3.635
- ROIC -0.1028
- MktCap 1204628470.0
- FreeCF/Share -0.2381
- PFCF -89.9245
- PE -50.8943
- Debt/Assets 0.0
- DivYield 0
- ROE -0.1407
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | OMDA | Robert W. Baird | -- | Neutral | -- | $24 | Sept. 5, 2025 |
| Initiation | OMDA | Canaccord Genuity | -- | Buy | -- | $27 | July 1, 2025 |
| Initiation | OMDA | Evercore ISI | -- | Outperform | -- | $21 | July 1, 2025 |
| Initiation | OMDA | Goldman | -- | Buy | -- | $29 | July 1, 2025 |
| Initiation | OMDA | Barclays | -- | Overweight | -- | $21 | July 1, 2025 |
| Initiation | OMDA | Morgan Stanley | -- | Overweight | -- | $25 | July 1, 2025 |
| Initiation | OMDA | Needham | -- | Buy | -- | $23 | July 1, 2025 |
| Initiation | OMDA | JP Morgan | -- | Overweight | -- | $19 | July 1, 2025 |
News
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs
Published: November 07, 2025 by: Business Insider
Sentiment: Positive
Trump said Thursday that TrumpRx would offer discounts on GLP-1 drugs for weight loss. A few hours later, Omada Health said it will prescribe the drugs starting in 2026.
Read More
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users
Published: November 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members currently or previously on GLP-1 medications for weight loss. Together, these analyses suggest that engagement with Omada may enhance results for members who have been on GLP-1s for weight loss, whether they stay on the medication or not.
Read More
Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
Published: October 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
The approach defies the restrictive weight loss paradigm, with early results indicating increased meal tracking and member engagement1 with new real-time, personalized nutrition guidance SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, launches Meal Map, a new nutrient-categorization tool that combines AI-powered instant feedback with human care teams to help members in its cardiometabolic programs understand the nutrient quality of their food choices. Built within Omada's Nutritional Intelligence capability, Meal Map is designed to help members make informed food choices, with an aim towards fostering confidence and long-term healthy habits.
Read More
About Omada Health (OMDA)
- IPO Date 2025-06-06
- Website https://www.omadahealth.com
- Industry Medical - Healthcare Information Services
- CEO Sean P. Duffy
- Employees 849